Eagle Global Advisors LLC Astrazeneca PLC Transaction History
Eagle Global Advisors LLC
- $2.48 Billion
- Q3 2025
A detailed history of Eagle Global Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Eagle Global Advisors LLC holds 53,536 shares of AZN stock, worth $4.79 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
53,536
Previous 53,536
-0.0%
Holding current value
$4.79 Million
Previous $3.74 Million
9.78%
% of portfolio
0.17%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,507Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...